Ginkgo Bioworks Holdings, Inc.
Status: Publicly traded
Direct answer
Ginkgo Bioworks Holdings, Inc. is publicly traded on NYSE under the ticker DNA.
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those...
Can you invest in Ginkgo Bioworks Holdings, Inc.?
Yes. Ginkgo Bioworks Holdings, Inc. is publicly traded on NYSE under the ticker DNA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ginkgo Bioworks Holdings, Inc.
Detailed equity research is provided by MarketSnap.